A Failure to Communicate... the Truth

Ocugen (OCGN): If you can’t trust management, what’s the point?

Greenwich LifeSciences (GLSI): Developing a placebo from a family of placebos

Applied Therapeutics (APLT): When you call every failure a success

Amylyx (AMLX): Is it a value or a value trap?

Relay (RLAY) Another over-hyped AI company

Relmada (RLMD): There are some issues with treating depression with an opiate

Altimmune (ALT): Odd drug out